[go: up one dir, main page]

BR9714509A - Formulações sólidas contendo trealose - Google Patents

Formulações sólidas contendo trealose

Info

Publication number
BR9714509A
BR9714509A BR9714509A BR9714509A BR9714509A BR 9714509 A BR9714509 A BR 9714509A BR 9714509 A BR9714509 A BR 9714509A BR 9714509 A BR9714509 A BR 9714509A BR 9714509 A BR9714509 A BR 9714509A
Authority
BR
Brazil
Prior art keywords
amount
active agent
trehalose
formulations containing
solid formulations
Prior art date
Application number
BR9714509A
Other languages
English (en)
Inventor
Joseph Bruce Roser
Julian Blair
Camilo Colaco
Morris Henry Ross Hatley
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27083298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9714509(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/599,277 external-priority patent/US5762961A/en
Priority claimed from US08/599,273 external-priority patent/US5958455A/en
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of BR9714509A publication Critical patent/BR9714509A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

todo de fazer formas de dosagem sólidas compreendedo uma quantidade de trealose suficiente para agir como um diluente eficaz nos tabletes formados e uma quantidade de um agente ativo, de modo que cada forma de dosagem formada contenha uma quantidade eficaz de agente ativo e uma quantidade de solvente aquoso suficiente para suspender ou dissolver a trealose e o agente ativo; b) processar o produto da etapa a) para formar um pó; grânulos ou microgrhomogênea dos componentes; e c) formar formas de dosagem do pó, grânulos ou microgrânulos em que o p
BR9714509A 1996-02-09 1997-02-10 Formulações sólidas contendo trealose BR9714509A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/599,277 US5762961A (en) 1996-02-09 1996-02-09 Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US08/599,273 US5958455A (en) 1996-02-09 1996-02-09 Oral solid dosage forms, methods of making same and compositions thereof
PCT/GB1997/000367 WO1997028788A1 (en) 1996-02-09 1997-02-10 Solid formulations containing trehalose

Publications (1)

Publication Number Publication Date
BR9714509A true BR9714509A (pt) 2000-03-21

Family

ID=27083298

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714509A BR9714509A (pt) 1996-02-09 1997-02-10 Formulações sólidas contendo trealose

Country Status (9)

Country Link
EP (1) EP0879048B2 (pt)
JP (1) JP2000505801A (pt)
CN (1) CN1213299A (pt)
AT (1) ATE265205T1 (pt)
AU (1) AU1729297A (pt)
BR (1) BR9714509A (pt)
CA (1) CA2245708C (pt)
DE (1) DE69728857T3 (pt)
WO (1) WO1997028788A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013740A1 (en) * 1998-03-27 2003-01-16 Martin P. Redmon Stable dosage forms of fluoxetine and its enantiomers
US6455096B1 (en) * 1998-04-28 2002-09-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hard candy with a relatively-high moisture and hardness, and process of the same
EP1097722B1 (en) * 1998-07-15 2005-11-02 Asahi Kasei Chemicals Corporation Excipient
WO2000013680A2 (en) * 1998-09-09 2000-03-16 Quadrant Holdings Cambridge Limited Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
GB2353933A (en) * 1999-09-09 2001-03-14 British Sugar Plc Compositions comprising trehalose for forming tablets
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
JP4493769B2 (ja) * 1999-12-21 2010-06-30 旭化成ケミカルズ株式会社 球形顆粒
FR2810258B1 (fr) * 2000-06-15 2004-11-12 Antony Guyader Gels d'electrophorese secs et rehydratables caracterises par une conservation longue duree
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
JP2002034472A (ja) * 2000-07-21 2002-02-05 Kanebo Ltd 温熱付与剤及びそれを用いた食品並びに加水食品の製法
EP1992335A1 (en) 2001-11-01 2008-11-19 Nektar Therapeutics Spray drying methods and compositions thereof
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP1460080A1 (en) * 2003-03-21 2004-09-22 Cargill Incorporated Direct compressible trehalose solids
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
CN101389323B (zh) * 2006-02-20 2013-08-21 中外制药株式会社 含有磷酸奥塞米韦的药物组合物
KR20130043236A (ko) * 2008-01-18 2013-04-29 아사히 가세이 파마 가부시키가이샤 안정한 의약 조성물
US8784884B2 (en) 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
GB201012539D0 (en) 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
CN107373662B (zh) * 2017-07-07 2020-12-22 江西清源汉本生物科技有限公司 速溶金银花提取物及其制备方法
CN107373663B (zh) * 2017-07-07 2020-12-25 江西清源汉本生物科技有限公司 速溶菊花提取物及其制备方法
CN107307422B (zh) * 2017-07-07 2018-09-18 许辉良 速溶石斛提取物及其制备方法
CN107595798B (zh) * 2017-09-26 2020-03-24 济川药业集团有限公司 一种琥珀酸普芦卡必利片剂及其制备方法
CN118370693B (zh) * 2024-04-01 2024-10-15 广州梵之容化妆品有限公司 一种分散组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
JP3168550B2 (ja) † 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
JP3773062B2 (ja) * 1993-01-29 2006-05-10 味の素株式会社 製剤用添加剤
EP2036541A1 (en) † 1994-03-07 2009-03-18 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
JP3793590B2 (ja) * 1994-06-27 2006-07-05 株式会社林原生物化学研究所 非還元性糖質とその製造方法並びに用途
DE69529026T2 (de) * 1994-07-19 2003-07-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Trehalose, ihre Herstellung und ihre Verwendung
US5556837A (en) † 1994-08-01 1996-09-17 Regeneron Pharmaceuticals Inc. Methods for treating addictive disorders

Also Published As

Publication number Publication date
EP0879048B1 (en) 2004-04-28
CA2245708A1 (en) 1997-08-14
JP2000505801A (ja) 2000-05-16
WO1997028788A1 (en) 1997-08-14
DE69728857T3 (de) 2010-02-18
DE69728857D1 (de) 2004-06-03
EP0879048B2 (en) 2009-07-29
CA2245708C (en) 2008-01-22
DE69728857T2 (de) 2005-04-21
CN1213299A (zh) 1999-04-07
EP0879048A1 (en) 1998-11-25
AU1729297A (en) 1997-08-28
ATE265205T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
BR9714509A (pt) Formulações sólidas contendo trealose
ES8501978A1 (es) Un procedimiento para preparar un agente anti-inflamatorio
HUP9900467A2 (hu) Savval szemben labilis, omeprazolt tartalmazó gyógyászati készítmény, és eljárás előállítására
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
EP1094788A4 (en) TASTE MASKING WITH CROSCARMELLOSE
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
IE822787L (en) Solid shaped article
DK0777964T3 (da) Fremgangsmåde til fremstilling af et doseringssystem
DE60020716D1 (de) Filmbildende zusammensetzungen aus pullulan
FR2692146B1 (fr) Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
CA2124568A1 (en) Method for producing microgranulated particle
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
DE69418468D1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
HUT66238A (en) Bicyclic carboxylic acid derivatives, pharmaceutical compositions contg. them as active agent and process to prepare them
EA199800435A1 (ru) Пестицидный препарат
PL355106A1 (en) Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
DZ3208A1 (fr) Comprimes faiblement doses et procédé de préparation.
FI935019A0 (fi) Menetelmä klodronaattivalmisteen valmistamiseksi
WO1997010810A3 (en) Pharmaceutical granules
ES2056122T3 (es) Un proceso para la fabricacion de pequeñas esferas gastrorresistentes y enterosolubles de enzima soluble y un preparado farmaceutico asi obtenido.
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
DE50201005D1 (de) Verfahren zur herstellung von tabletten aus pflanzlichen extrakten
JPS5242474A (en) Press roll for granulation
NO920183D0 (no) Preparat omfattende en aktiv bestanddel, fortrinnsvis i pulver- eller partikkelform, samt en baerer for den aktive bestanddel og fremgangsmaate til fremstilling av et slikt preparat

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1865 DE 03/10/2006.